Paper2016707
2-Alkoxyadenosines: potent and selective agonists at the coronary artery A2 adenosine receptor.
Ueeda M and 3 others. J Med Chem, 1991. Cited by 56 papers, by iCite.
Cite this record
ConductScience Library. 2-Alkoxyadenosines: potent and selective agonists at the coronary artery A2 adenosine receptor. Papers, record 2016707. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2016707
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenosine | Major topic |
| Coronary Vessels | Major topic |
| Heart | Major topic |
| Muscle, Smooth, Vascular | Major topic |
| Receptors, Purinergic | Major topic |
| Animals | |
| Atrioventricular Node | |
| Guinea Pigs | |
| In Vitro Techniques | |
| Models, Molecular | |
| Molecular Conformation | |
| Molecular Structure | |
| Rats | |
| Structure-Activity Relationship |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| HL 30391 | NHLBI NIH HHS | United States | R01HL030391 | PubMed and NIH |
Source NIH RePORTER
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 56 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37741687 | A2A adenosine receptor agonists, antagonists, inverse agonists and partial agonists. | Int Rev Neurobiol | 2023 | https://conductscience.org/library/papers/37741687 | PubMed |
| 31907833 | Comparison of trinitroglycerin and adenosine as provocative agents for head-up tilt test in patients with unexplained syncope: a semi-crossover randomized clinical trial with prospective follow-up. | J Interv Card Electrophysiol | 2021 | https://conductscience.org/library/papers/31907833 | PubMed |
| 15476669 | 2-Substituted adenosine derivatives: affinity and efficacy at four subtypes of human adenosine receptors. | Biochem Pharmacol | 2004 | https://conductscience.org/library/papers/15476669 | PubMed |
| 12673185 | Pharmacologic stress testing: new methods and new agents. | J Nucl Cardiol | 2003 | https://conductscience.org/library/papers/12673185 | PubMed |
| 9831724 | Cellular mechanisms by which adenosine induces vasodilatation in rat skeletal muscle: significance for systemic hypoxia. | J Physiol | 1999 | https://conductscience.org/library/papers/9831724 | PubMed |
| 9831723 | Adenosine receptor subtypes and vasodilatation in rat skeletal muscle during systemic hypoxia: a role for A1 receptors. | J Physiol | 1999 | https://conductscience.org/library/papers/9831723 | PubMed |
| 9019545 | The role of the A(2A) adenosine receptor subtype in functional hyperaemia in the hindlimb of anaesthetized cats. | J Physiol | 1996 | https://conductscience.org/library/papers/9019545 | PubMed |
| 8692279 | Functional characterization of adenosine A2 receptors in Jurkat cells and PC12 cells using adenosine receptor agonists. | Naunyn Schmiedebergs Arch Pharmacol | 1996 | https://conductscience.org/library/papers/8692279 | PubMed |
| 8321327 | Covalent binding of a selective agonist irreversibly activates guinea pig coronary artery A2 adenosine receptors. | Naunyn Schmiedebergs Arch Pharmacol | 1993 | https://conductscience.org/library/papers/8321327 | PubMed |
| 8097283 | The cardiovascular effects of selective adenosine A1 and A2 receptor agonists in the pithed rat: no role for glibenclamide-sensitive potassium channels. | Naunyn Schmiedebergs Arch Pharmacol | 1993 | https://conductscience.org/library/papers/8097283 | PubMed |
| 7925617 | Molecular modeling of adenosine receptors. The ligand binding site on the rat adenosine A2A receptor. | Eur J Pharmacol | 1994 | https://conductscience.org/library/papers/7925617 | PubMed |
| 7582508 | The in vitro pharmacology of ZM 241385, a potent, non-xanthine A2a selective adenosine receptor antagonist. | Br J Pharmacol | 1995 | https://conductscience.org/library/papers/7582508 | PubMed |
| 1738138 | Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential. | J Med Chem | 1992 | https://conductscience.org/library/papers/1738138 | PubMed |
| 1513184 | Adenosine A1 and A2 receptors: structure--function relationships. | Med Res Rev | 1992 | https://conductscience.org/library/papers/1513184 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2016707
GET https://conductscience.org/api/papers/v1/2016707/authors